Skip to content
A Green Sign – Lifestyle
Author:
IXL Learning, Inc.
Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer
August 14, 2026
Major Milestone: IXL Learners Answer 200 Billion Questions
June 18, 2026
Rigel Enters Exclusive Global Licensing Agreement for VEPPANU™ (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer
May 12, 2026
A Way With Words: Dictionary.com Names Winner of National Poetry Month Competition
April 30, 2026
Springing Forward: The Vocabulary Bowl Breaks Record After Record
April 23, 2026
Dictionary.com’s 2026 Winter Word Drop Embraces Innovation, Goes Global and Enters the Chat
March 5, 2026